Catherine Thorpe is the Chief Accounting Officer and interim Principal Financial Officer at Applied Therapeutics since June 2023. With a strong background in accounting, she previously held the position of Managing Director at CFGI, where she led efforts in financial...
Catherine Thorpe is the Chief Accounting Officer and interim Principal Financial Officer at Applied Therapeutics since June 2023. With a strong background in accounting, she previously held the position of Managing Director at CFGI, where she led efforts in financial consulting. She has been pivotal in navigating key data and operational strategies for Applied Therapeutics, especially after the departure of former CFO Steven Ortega. Her appointment came at a time when the company was restructuring and needed clear financial oversight. Thorpe's extensive experience is focused on firm financial governance, a crucial aspect for a company engaged in drug development. While her educational background is not listed, her career trajectory showcases significant expertise in managing complex financial environments. In 2023, her total compensation was reported at around $9.5 million, which included a base salary of $630,000, showing that her worth to the company is recognized, particularly during a period of growth and potential in the health sector. Under her financial leadership, Applied Therapeutics is set to tackle FDA challenges as it seeks approval for new drug applications.